Anne Reitz
Nurse Practitioner · Angola, INNPI 1376715185
Payments from drug & device makers
Across 257 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$992
- AbbVie$528
- Novo Nordisk$412
- Lilly USA, LLC$407
- GSK$340
- Axsome Therapeutics, Inc.$320
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,89899%
- Other$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 47 | $992 |
| AbbVie | 40 | $528 |
| Novo Nordisk | 24 | $412 |
| Lilly USA, LLC | 19 | $407 |
| GSK | 25 | $340 |
| Axsome Therapeutics, Inc. | 8 | $320 |
| Biohaven Pharmaceuticals, Inc. | 5 | $227 |
| Boehringer Ingelheim | 11 | $185 |
| Amarin Pharma, Inc. | 8 | $128 |
| UCB, Inc. | 1 | $124 |
| Dexcom, Inc. | 7 | $119 |
| Abbott | 5 | $115 |
| Pfizer | 6 | $112 |
| Therapeuticsmd, Inc. | 1 | $100 |
| Exact Sciences | 6 | $96 |
| Xeris Pharmaceuticals, Inc. | 5 | $89 |
| Astellas Pharma US Inc | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Amgen | 5 | $72 |
| Johnson & Johnson | 4 | $68 |
| Corium, LLC | 4 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Bayer | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Philips North America LLC | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| Organogenesis Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,948 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 51 | $50,600 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $49,235 |
| JardianceEmpagliflozin | 47 | $42,962 |
| OzempicSemaglutide | 39 | $42,902 |
| RybelsusSemaglutide | 24 | $38,549 |
| TrulicityDulaglutide | 25 | $36,143 |
| JanuviaSitagliptin Phosphate | 30 | $29,082 |
| EliquisApixaban | 17 | $17,924 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 30 | $14,791 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $13,851 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $13,746 |
| VascepaIcosapent Ethyl | 27 | $10,408 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 51 | $6,300 |
| Aripiprazole | 27 | $3,764 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 143 | $3,548 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $412 | $81,45163 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $992 | $64,45167 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $340 | $64,02679 claims |
| Boehringer IngelheimJardiance | $185 | $42,96247 claims |
| MerckJanuvia, Janumet | $12 | $42,82946 claims |
| Lilly USA, LLCTrulicity | $407 | $36,14325 claims |
| PfizerEliquis | $112 | $17,92417 claims |
| AbbVieSynthroid | $528 | $92113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Angola
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.